Korean J Dermatol.
2005 Oct;43(10):1423-1425.
A Case of Acneiform Eruption Occurring after Injection of Cetuximab (Erbitux(R), IMC-C225)
- Affiliations
-
- 1Department of Dermatology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. dylee@smc.samsung.co.kr
Abstract
- We report a case of acneiform skin eruption induced by cetuximab in a 58-year-old man. Cetuximab is a new anticancer agent, which acts as a selective epidermal growth factor receptor monoclonal antibody. Our patient had taken cetuximab for the treatment of metastatic rectal cancer and visited our clinic with multiple erythematous papules and pustules on the face, postauricular area and anterior chest. A skin biopsy from his forehead revealed destruction of the follicular structure and perifollicular inflammatory cellular infiltrations composed of neutrophils and lymphocytes.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Case of Paronychia Occurring after Injection with Cetuximab (Erbitux(R), IMC-C225)
- Severe Acneiform Eruption Induced by Cetuximab (Erbitux(R))
- Two Cases of Acneiform Eruption Caused by Epidermal Growth Factor Receptor Inhibitors
- Clinical Features of the Cutaneous Adverse Events Induced by Combination Chemotherapy that Includes Cetuximab (Erbitux(R))
- A Case of Acneiform Eruption on the Healed Site of Herpes Zoster
